Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers

被引:39
|
作者
Yeh, Matthew M. [1 ]
Daniel, Hubert Darius-J [2 ]
Torbenson, Michael [2 ]
机构
[1] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
关键词
hepatitis C virus; hepatocellular carcinoma; non-cirrhotic liver; BETA-CATENIN MUTATIONS; ADENOMATOUS HYPERPLASIA; UNITED-STATES; B-VIRUS; INFECTION; HEPATOCARCINOGENESIS; PROGNOSIS; CIRRHOSIS; CANCER; GENE;
D O I
10.1038/modpathol.2009.174
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Chronic hepatitis C viral infection can lead to cirrhosis and hepatocellular carcinoma. It is generally believed that hepatitis C infection is not oncogeneic per se, but that the presence of cirrhosis determines the increased risk for hepatocellular carcinoma. However, a search of surgical pathology files from two large tertiary care centers for the years 2001-2008 identified a total of 18 hepatocellular carcinomas in non-cirrhotic livers with chronic hepatitis C infection. In six cases the background livers showed bridging fibrosis, while the remainder showed lower stages of fibrosis. Cases were negative for clinical and serological evidence of hepatitis B co-infection, and occult hepatitis B test was negative by PCR of formalin-fixed, paraffin embedded tissues. The tumors were also negative for TP53, exon 7, codon 249 mutations, a characteristic mutation strongly linked to aflatoxin exposure. The hepatocellular carcinomas had typical histology with no enrichment for unusual growth patterns or histological features. Among all resected hepatocellular carcinomas in non-cirrhotic livers over this time period, the prevalence of 16% with HCV infection was significantly greater than that expected by chance. In conclusion, these results demonstrate that hepatocellular carcinomas can arise in livers chronically infected with hepatitis C but without cirrhosis. These findings raise the possibility that in some cases hepatitis C infection and inflammation can be directly oncogeneic. It is also possible that established cirrhosis may have regressed in some cases. Regardless of the mechanism, these findings highlight an important and previously under-recognized risk for hepatocellular carcinoma in HCV-infected individuals who do not have cirrhosis. Modern Pathology (2010) 23, 276-283; doi: 10.1038/modpathol.2009.174; published online 20 November 2009
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [21] Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review
    Liu, Yan
    Li, Hao
    Ye, Nan
    Luo, Cheng-Jun
    Hu, Ye-Yu
    Wu, Hao
    Gong, Jian-Ping
    MEDICAL SCIENCE MONITOR, 2019, 25 : 6615 - 6623
  • [22] Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver
    Schmelzle, M.
    Krenzien, F.
    Schoening, W.
    Pratschke, J.
    CHIRURG, 2018, 89 (11): : 851 - 857
  • [23] Hepatocellular carcinoma in the non-cirrhotic liver
    Evert, M.
    Dombrowski, F.
    PATHOLOGE, 2008, 29 (01): : 47 - 52
  • [24] AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma
    Kwon, Jung-Hee
    Ahn, Keun Soo
    Moon, Young Ho
    Park, Jin Young
    Wang, Hee Jung
    Choi, Kwan Yong
    Kim, Gundo
    Joh, Jae Won
    Lee, Kyeong Geun
    Kang, Koo Jeong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (09) : 1253 - +
  • [25] Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
    Kerstin Schütte
    Christian Schulz
    Janine Poranzke
    Kai Antweiler
    Jan Bornschein
    Tina Bretschneider
    Jörg Arend
    Jens Ricke
    Peter Malfertheiner
    BMC Gastroenterology, 14
  • [26] Spontaneous rupture of hepatocellular carcinoma in a non-cirrhotic liver
    Paschos, K.
    Xatzigeorgiadis, A.
    Maskanakis, A.
    Melidis, D.
    Fragoudi, A.
    Ioannidis, K.
    SCIENTIFIC CHRONICLES, 2012, 17 (04) : 234 - 238
  • [27] Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
    Aakash Desai
    Sonia Sandhu
    Jin-Ping Lai
    Dalbir Singh Sandhu
    World Journal of Hepatology, 2019, (01) : 1 - 18
  • [28] Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver
    Woerns, Marcus A.
    Bosslet, Timon
    Victor, Anja
    Koch, Sandra
    Hoppe-Lotichius, Maria
    Heise, Michael
    Hansen, Torsten
    Pitton, Michael B.
    Niederle, Ina M.
    Schuchmann, Marcus
    Weinmann, Arndt
    Dueber, Christoph
    Galle, Peter R.
    Otto, Gerd
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) : 718 - 728
  • [29] Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver
    Shiraishi, M
    Takushi, Y
    Simoji, H
    Oshiro, T
    Shinzato, S
    Tanigawa, N
    Kusano, T
    Muto, Y
    JOURNAL OF GASTROENTEROLOGY, 1998, 33 (04) : 593 - 596
  • [30] Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers
    Witjes, Caroline D. M.
    Polak, Wojciech G.
    Verhoef, Cornelis
    Eskens, Ferry A. L. M.
    Dwarkasing, Roy S.
    Verheij, Joanne
    de Man, Robert A.
    Ijzermans, Jan N. M.
    DIGESTIVE SURGERY, 2012, 29 (06) : 522 - 528